00:01
Let's move on to the zona glomerulosa
and mineralocorticoid function.
00:07
Now remember that when we are talking about
mineralocorticoids or even corticosteroids,
we are talking about using a steroid receptor.
00:15
If you remember from your pharmacology
lectures way back at the beginning,
when we were looking at receptors,
there are five major types of receptors.
00:24
Steroid receptors are intracellular receptors
and so the drug, because it's lipophilic
can cross the membrane easily and that's
how the medications or the hormones work.
00:37
Now, if the steroid binds to
the receptor inside the cell,
it has to send a message into the nucleus.
00:45
It does so through something called an
MRE or mineralocorticoid response element.
00:51
This MRE is part of the DNA molecule.
00:55
The MRE exerts its effects through DNA and
you have production of certain enzymes.
01:02
Now the aldosterone agonists are
part of the renin angiotensin system,
and they have a very strong salt retaining
activity just like androgynous mineralocorticoids.
01:12
So, aldosterone agonists are also considered
mineralocorticoids as well as diuretics.
01:19
A good example of a mineralocorticoid
is Florinef or fludrocortisone.
01:25
Structurally it's very similar to cortisol.
01:28
It has moderate glucocorticoid activity
and very strong mineralocorticoid activity.
01:34
It is involved and can be treating
cerebral salt wasting syndrome.
01:39
It can be used in Addison's disease.
01:42
It can be used in this disease called POTS or
paroxysmal orthostatic tachycardia syndrome.
01:48
And it's also sometimes used in geriatric
orthostatic hypotensive syncope.
01:53
So, what we're doing here is we're retaining salt
so that the blood pressures are a little bit higher
and it prevents the drop in blood pressure that
geriatric patients have when they stand up.
02:06
Spironolactone is a diuretic.
02:10
We discussed it already in the
hypertension section of pharmacology,
but we also use it as its mineralocorticoid
function to treat hirsutism.
02:20
It has anti-androgen and
mineralocorticoid effect activity.
02:24
Let's move on to the zona fasciculata.
02:27
This is where glucocorticoid
production is occuring.
02:31
Now, glucocorticoids also enter
the cell as a free molecule.
02:35
It doesn't need to be converted
because it's already lipophilic.
02:39
It binds to the intracellular
receptor or other proteins,
and then enters into the nucleus as a complex.
02:46
Now, instead of an MRE, it binds to a GRE
or the glucocorticoid response element
which is still also a portion of the DNA.
02:56
The GRE regulates gene expression and
transcription for its various functions.
03:03
Now, when we use synthetic glucocorticoids
in patients, we have side effects.
03:07
That metabolic effect can be gluconeogenesis,
lipolysis and reduced subdermal fat.
03:14
Morphologic changes can have
lipid deposits in certain spots
such as the face, the neck, and the shoulder.
03:21
So I want to go over that
just again so it's clear.
03:24
Reduced subdermal fat refers
to, say the back of the skin,
so people will have parchment-like skin when
they are given synthetic glucocorticoids
for a long time.
03:34
People who are given synthetic glucocorticoids
will have more fat in the face, shoulder and neck.
03:39
So, I say that they have a 'moon face',
they have a round kind of full face,
but they have thin parchment-like skin.
03:49
There are some catabolic effects as well.
03:51
Protein catabolism, and tissue
wasting, and osteoporotic effects
are all part and parcel of
glucocorticoid excess activity.
04:00
So in other words, patients who are
placed on synthetic glucocorticoids
can have protein wasting and
reduction of muscle mass.
04:09
And osteoporosis is a major concern.
04:12
And premature bone fracture is a
major concern on people who are taking
synthetic glucocorticoids for a long time.
04:19
Side effects can also be immunosuppressive as well.
04:23
Cell mediated immunity can be affected
by long term glucocorticoid use.
04:28
For example, lymphocyte-dependent
infections can become more rampant
and so you have to be very careful of
patients developing severe viral infections
or increased susceptability to viral infections.
04:42
Renal function can be compromised.
04:44
Remember cortisol is normally
required for water excretion.
04:48
Anti-inflammatory effects,or actually, I
wouldn't call it necessarily a side effect,
it's actually the effect we are looking for.
04:55
There is often a dramatic
suppression of multiple markers.
04:59
That's often why we use synthetic
glucocorticoids in high doses in the first place.
05:04
There is some neuropsychiatric issues.
05:07
Excess cortisol causes giddiness and
euphoria, and synthetic cortisol derivatives
can cause that same kind of behaviour change.
05:18
The prototypical synthetic
glucocorticoid is prednisone.
05:23
It has a long half life, it has
quite good membrane penetration,
and it's often used in acute
inflammation in most disease states.
05:32
It's often a steroid replacement therapy as
well for people who have adrenal suppresion.
05:38
Dexamethasone is another synthetic glucocorticoid.
05:43
It has an even longer half life
than the original prednisone.
05:47
It has even better membrane penetration.
05:50
It is often used in cancer chemotherapy as
part of an adjunctive treatment regimen.
05:57
Triamcinolone, beclomethasone,
budesonide are other glucocorticoids.
06:02
Beclomethasone is readily
penetrating the respiratory mucosa
so we often use it in pulmonary inhalers.
06:11
Let's take a look at glucocorticoid
synthesis inhibitors.
06:15
Now this is a drug, or a set of
drugs that we use to actually reduce
excess endogenous cortisol production.
06:23
Now, interestingly enough, ketoconazole, you
might recognize this as antifungal medication.
06:28
We do use it in adrenal adenoma,
breast cancer and prostate cancer.
06:32
And it is also used in hirsutism for
the treatment of excess cortisol levels.
06:38
Metyrapone is another medication that
we use in glucocoritcoid pharmacology.
06:43
It inhibits synthesis of cortisol.
06:46
We actually use it more for diagnositic
testing rather than actual therapy.
06:52
Other agent blocks conversion of
cholesterol to the precursors of cortisol
and other endogenous steroids.
06:59
It is used in steroid producing cancers
to prevent excess steroid in the body.
07:06
The zona reticularis function and adrenal
androgens has been covered in another lecture,
so I won't go into too much detail here.